Daniel Kraft

A grounded look at generative, multimodal, and agentic AI: where it delivers value today, where the evidence is still thin, and where the claims outrun the capability. Kraft covers applications across clinical documentation, decision support, diagnostics, patient engagement, and enterprise operations, and explains what separates real deployment from pilots that never scale: usable data, clinical validation, workflow integration, governance, workforce readiness, and a payment model that works, with human judgment kept in the loop. Audiences leave knowing which applications to back first and what to ask before scaling any of them.

For biopharma leadership, R&D, commercial, medical affairs, and market access teams. Kraft maps where AI is changing the economics of discovery and development, from target identification and molecular design to trial design, synthetic control arms, and regulatory submission, and reframes the patient journey as one connected layer that shortens time to diagnosis and clarifies adherence and response. He explains why companies with a differentiated data position will separate from those buying the same tools as everyone else, sending leadership teams home with a clear read on their own data position and the validation bar their AI claims should meet.

Drawing on his work as a Kauffman Fellow and General Partner at Continuum Health Ventures, Kraft shows investor groups, private equity, venture capital, and family offices how AI, advanced diagnostics, longevity, and new models of care are rewriting business models across the sector. Scientific progress creates possibilities; adoption decides which become durable businesses. He shows how reimbursement, workflow fit, and data advantage separate technical promise from commercial readiness, and leaves investors with sharper diligence questions and the Now, Near and Next framework applied to their own portfolio horizons.

A stem cell biologist trained in hematology, oncology, and bone marrow transplantation, Kraft brings a clinician’s eye to separating longevity science from longevity marketing. He traces the shift from treating illness after it appears toward proactive, personalized health, examines what the evidence supports across metabolic health, sleep, continuous monitoring, and consumer diagnostics, and flags the emerging science worth watching, from cellular reprogramming to regenerative and gene-based approaches. Audiences leave able to tell established practice from experimental claims while keeping access and human factors firmly in view.

For diagnostics, laboratory, imaging, pathology, and life sciences audiences. Kraft shows how wearables, digital biomarkers, at-home testing, and low-cost personal omics reveal what is happening between clinical visits, and weighs the promise and the limits of multi-cancer early detection, liquid biopsy, computational pathology, and AI-assisted imaging. As the lab moves from the end of the workup to the front of prediction, he presses the questions that matter: who should be tested, how findings are validated, and whether earlier detection actually improves outcomes. The takeaway is a practical test for any emerging diagnostic: does better detection lead to appropriate action and measurable patient benefit?

For health systems, provider organizations, and care delivery audiences. Kraft shows how prevention, diagnostics, and selected acute care are moving beyond the hospital and the clinic, and what the hospital becomes as a result. He covers remote monitoring, home diagnostics, virtual care, and hospital-at-home, including the operational reasons promising programs stall before they scale, and the evolving clinician role from virtualist to AI-augmented teams. Health system leaders leave with a clear view of which services can move closer to patients and what patient selection, staffing, escalation pathways, and reimbursement it takes to deliver them safely and at scale.

A facilitated strategy session for boards and executive leadership teams, drawing on Kraft’s role as founding faculty and chair of medicine at Singularity University and more than a decade leading Exponential Medicine, now NextMed Health. Run over two to three hours or inside a half- or full-day agenda, the session locates where AI, digital health, and emerging medicine touch the organization’s specific strategy across Now, Near and Next, set against what competitors are actually doing. It starts with the data question, moves through talent, leadership, and governance gaps, and produces a shared view of priorities and next steps captured in a written summary. Recent sessions include the boards of Argenx and Atrium Health and the executive leadership teams of Teva and Roche.

Yes. Daniel Kraft, MD, studied medicine at Stanford and is board certified in both internal medicine and pediatrics after a Harvard residency at Massachusetts General Hospital and Boston Children’s Hospital. He completed fellowships in hematology, oncology, and bone marrow transplantation at Stanford, where he now serves as an Adjunct Professor of Medicine.

He is the inventor of the FDA-cleared MarrowMiner, a device for minimally invasive bone marrow harvest, and the founder of RegenMed Systems. He holds patents spanning medical devices, immunology, and stem cell therapies, and his laboratory research in stem cell biology and cancer immunotherapy has been published in Nature and Science.

His lineup spans AI in healthcare, the future of biopharma, investing in health innovation, longevity and healthspan, earlier detection and prevention, and the shift from hospital to home, all organized around his Now, Near and Next framework. He also leads closed-door executive strategy sessions for boards and leadership teams. Audiences from health systems, biopharma, and global summits consistently rank him among the most forward-looking voices in medicine. Reach out to Aurum Speakers Bureau to tailor a talk to your event.

Aurum Speakers Bureau can help you book Daniel Kraft as a speaker for your next event, conference, or board meeting. Simply fill out our contact form to inquire about Daniel Kraft's availability for a speaking engagement. One of our booking agents will respond to your request immediately and contact the speaker to let them know you want to hire them. We will assist you with obtaining speaking fees, booking information, and confirming availability for Daniel Kraft or any other top keynote speaker or celebrity of your choice.

Daniel Kraft speaking fees are determined by several factors, including the event's date, whether it's a virtual or in-person event, the duration, format, preparation required for their speech, and more. The same applies to the cost to hire any other top expert speakers and celebrities. The Speaker Fee Range listed on our website is simply a guideline and is subject to change without notice. If you would like to hire Daniel Kraft to deliver a keynote speech for your event, please fill out the contact form or email us at info@aurumbureau.com with as much detail as possible. One of our experienced agents will get in touch with you and let you know exactly how much it will cost to book Daniel Kraft.

We only work with Daniel Kraft on paid speaking engagements. Aurum Speakers Bureau can assist you in booking Daniel Kraft and will handle all negotiations, contracts, and logistics associated with having Daniel Kraft speak at your event. We will be your sole point of contact throughout the process. Get in touch with Aurum Speakers Bureau today, and we will reach out to any motivational speaker or celebrity you want to enquire about speaking at your event. If you wish to contact Daniel Kraft for any other reason, we will be unable to assist you as we are not authorized to provide personal contact information.

Yes, Daniel Kraft is available for virtual keynotes and webinars. To book Daniel Kraft for a virtual event, please complete the contact form or send us an email to inquire about the special fees for virtual engagements.